{
  "pmcid": "5514369",
  "sha256": "0310967e6d1139f8845cb52f30dce57ce57fd00c8fde5cf607c5c1fc2f65ac28",
  "timestamp_utc": "2025-11-09T22:46:38.296591+00:00",
  "model_used": "gpt-4o",
  "readability": {
    "flesch_kincaid": 13.433980519480517,
    "reading_ease": 19.31954220779224,
    "word_count": 231
  },
  "consort_scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 1,
        "evidence": "Randomised Controlled Trial of 17 β-Estradiol in Postmenopausal Women Undergoing Cardiac Surgery"
      },
      "Trial_Design": {
        "score": 1,
        "evidence": "A total of 174 postmenopausal women were randomly assigned"
      },
      "Participants": {
        "score": 2,
        "evidence": "Participants were recruited from a single cardiac surgery center."
      },
      "Intervention": {
        "score": 2,
        "evidence": "randomly assigned to receive either 17 β-estradiol or placebo"
      },
      "Objective": {
        "score": 1,
        "evidence": "This randomised controlled trial evaluated the impact of perioperative 17 β-estradiol on neurocognitive dysfunction and quality of life"
      },
      "Method_Outcome": {
        "score": 2,
        "evidence": "The primary outcome was neurocognitive dysfunction, assessed using a standard psychometric battery at baseline, 4 to 6 weeks, and 6 months postoperatively."
      },
      "Randomisation_Allocation": {
        "score": 2,
        "evidence": "Randomisation was computer-generated, and allocation was concealed."
      },
      "Blinding": {
        "score": 3,
        "evidence": "Blinding included patients, clinicians, and outcome assessors."
      },
      "Number_Randomised": {
        "score": 1,
        "evidence": "A total of 174 postmenopausal women were randomly assigned"
      },
      "Number_Analysed": {
        "score": 1,
        "evidence": "Of the 174 participants, 108 completed the study (54 in each group)."
      },
      "Result_Outcome": {
        "score": 2,
        "evidence": "Thirteen percent exhibited neurocognitive dysfunction postoperatively."
      },
      "Harms": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Trial_Registration": {
        "score": 0,
        "evidence": "Trial registration: [Trial registration number]"
      },
      "Funding": {
        "score": 0,
        "evidence": "Funding: [Source of funding]"
      }
    },
    "total_score": 18,
    "max_score": 25
  }
}